M&A
Cohance acquires 65% in US-based Aruka Bio for $5-M
BSE Announcement Business Line
Hyderabad-based Cohance Lifesciences (formerly known as Suven Pharmaceuticals) is to invest USD 5-M to acquire a 65% controlling stake in Aruka Bio , a Princeton, NJ (USA)-based biotechnology company that develops next-generation antibody-drug conjugate therapies.This move aims to position Aruka Bio to pursue collaborations and licensing with pharmaceutical partners.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
